HDFC Life Insurance Company Ltd
HDFC Life Insurance Company is engaged in carrying on the business of life insurance. The Company offers a range of individual and group insurance solutions. The portfolio comprises of various insurance and investment products such as Protection, Pension, Savings,(Source : 202003 Annual Report Page No: 175)
- Market Cap ₹ 106,922 Cr.
- Current Price ₹ 497
- High / Low ₹ 621 / 458
- Stock P/E 70.7
- Book Value ₹ 57.4
- Dividend Yield 0.34 %
- ROCE 11.7 %
- ROE 10.9 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 19.0%
Cons
- Stock is trading at 8.66 times its book value
- Tax rate seems low
- Earnings include an other income of Rs.929 Cr.
- Promoter holding has decreased over last 3 years: -15.9%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Insurance Industry: Finance & Investments
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
14,060 | 17,166 | 27,215 | 18,141 | 30,647 | 32,260 | 38,857 | 29,380 | 71,528 | 67,126 | 66,831 | |
13,535 | 16,561 | 26,341 | 17,187 | 29,674 | 31,186 | 37,643 | 28,239 | 70,294 | 66,348 | 66,216 | |
Operating Profit | 525 | 605 | 874 | 953 | 972 | 1,074 | 1,215 | 1,141 | 1,235 | 778 | 615 |
OPM % | 4% | 4% | 3% | 5% | 3% | 3% | 3% | 4% | 2% | 1% | 1% |
28 | 241 | 79 | 108 | 139 | 282 | 136 | 369 | 445 | 766 | 929 | |
Interest | 15 | 11 | -14 | 8 | 9 | 11 | 14 | 0 | 0 | 0 | 0 |
Depreciation | 35 | 41 | 43 | 45 | 41 | 44 | 45 | 47 | 51 | 56 | 0 |
Profit before tax | 502 | 794 | 924 | 1,008 | 1,061 | 1,300 | 1,291 | 1,463 | 1,629 | 1,487 | 1,544 |
Tax % | 11% | 9% | 15% | 19% | 16% | 15% | 1% | 11% | 16% | 11% | |
Net Profit | 447 | 725 | 786 | 817 | 887 | 1,107 | 1,278 | 1,297 | 1,361 | 1,327 | 1,513 |
EPS in Rs | 2.24 | 3.64 | 3.94 | 4.09 | 4.44 | 5.50 | 6.33 | 6.43 | 6.73 | 6.28 | 7.11 |
Dividend Payout % | 0% | 14% | 18% | 22% | 25% | 25% | 26% | 0% | 30% | 27% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 17% |
3 Years: | 20% |
TTM: | -3% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 8% |
3 Years: | 4% |
TTM: | 33% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 3% |
3 Years: | 13% |
1 Year: | -5% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 15% |
Last Year: | 11% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Sep 2022 | |
---|---|---|---|---|---|---|---|---|---|---|---|
1,995 | 1,995 | 1,995 | 1,995 | 1,998 | 2,012 | 2,017 | 2,019 | 2,021 | 2,113 | 2,149 | |
Reserves | -658 | -67 | 546 | 1,108 | 1,828 | 2,693 | 3,625 | 4,788 | 6,619 | 13,501 | 10,198 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 600 | 600 | 950 | |
40,581 | 50,347 | 66,767 | 73,441 | 91,270 | 105,778 | 124,378 | 125,417 | 170,415 | 214,521 | 218,930 | |
Total Liabilities | 41,918 | 52,275 | 69,309 | 76,544 | 95,097 | 110,483 | 130,020 | 132,224 | 179,655 | 230,734 | 232,228 |
252 | 279 | 346 | 335 | 337 | 336 | 324 | 322 | 585 | 6,605 | 367 | |
CWIP | 29 | 10 | 6 | 12 | 16 | 5 | 10 | 8 | 14 | 20 | 0 |
Investments | 40,404 | 50,527 | 67,024 | 74,144 | 91,723 | 106,590 | 124,958 | 127,256 | 173,564 | 216,551 | 224,959 |
1,232 | 1,458 | 1,932 | 2,053 | 3,020 | 3,551 | 4,729 | 4,637 | 5,493 | 7,559 | 6,902 | |
Total Assets | 41,918 | 52,275 | 69,309 | 76,544 | 95,097 | 110,483 | 130,020 | 132,224 | 179,655 | 230,734 | 232,228 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
4,459 | 5,687 | 6,230 | 6,739 | 9,868 | 7,388 | 9,703 | 5,943 | |||
-3,514 | -3,962 | -5,177 | -4,421 | -10,182 | -7,789 | -8,952 | -1,580 | |||
-168 | -212 | -236 | -196 | -337 | 38 | 678 | -238 | |||
Net Cash Flow | 777 | 1,513 | 817 | 2,122 | -651 | -364 | 1,429 | 4,125 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
Inventory Days | ||||||||||
Days Payable | ||||||||||
Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
Working Capital Days | -22 | -11 | -11 | -27 | -20 | -25 | -16 | -17 | -13 | -11 |
ROCE % | 49% | 41% | 36% | 31% | 31% | 23% | 24% | 20% | 12% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
1d - Allotment of 32,367 Equity Shares under Employee Stock Option Schemes
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17 Mar - Details of investor meet held on March 16, 2023, where senior management of the Company interacted with investors.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
15 Mar - Details of investor meets held on March 14, 2023, where senior management of the Company interacted with investors.
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
27 Feb - Allotment of 15,396 equity shares under Employee Stock Option Schemes
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22 Feb - Details of investor conference held on February 21, 2023, where senior management of the Company interacted with the investors.
Annual reports
Concalls
-
Jan 2023TranscriptPPT
-
Nov 2022TranscriptPPT
-
Jul 2022TranscriptPPT
-
May 2022TranscriptPPT
-
Aug 2018TranscriptNotesPPT
Started As Joint Venture
HDFC Life is incorporated as a JV between HDFC and Standard Life Aberdeen and is one of India's leading life insurance companies[1]